Patents by Inventor Thomas Chambers
Thomas Chambers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12350328Abstract: The present invention provides compositions and methods related to equine live-attenuated influenza vaccines. In one aspect, the invention relates to a composition comprising a multivalent equine live-attenuated influenza vaccine comprising a first live-attenuated influenza virus expressing one or more antigens of a clade 1 H3N8 equine influenza virus; and a second live-attenuated influenza virus expressing one or more antigens of a clade 2 H3N8 equine influenza virus, wherein the second live-attenuated influenza virus expresses HA, NA, or a combination thereof of A/equine/Lancashire/1/2016 H3N8.Type: GrantFiled: February 27, 2020Date of Patent: July 8, 2025Assignees: University of Rochester, UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION, ZOETIS SERVICES LLCInventors: Luis Martinez-Sobrido, Thomas Chambers, Kendall Wayne King
-
Publication number: 20250150744Abstract: Various implementations include open-ear headphones. In some cases, an open-ear headphone includes: an acoustic module for providing an audio output to an ear of a user; a battery housing; and a flexible arm physically and electrically coupling the acoustic module to the battery housing, the flexible arm including: a flexible printed circuit connecting the battery housing and the acoustic module, and a flexible material that encases at least some of the flexible printed circuit, where when worn, the acoustic module is located in a concha of the ear, the battery housing is located behind the ear, and the flexible arm passes over an outer side of at least one of at least one of an anti-helix, a helix, or a lobule of the ear.Type: ApplicationFiled: January 8, 2025Publication date: May 8, 2025Inventors: Thomas Chambers, Caitlin Hanson
-
Patent number: 12225341Abstract: A flexible arm that is configured to be located between and physically and electrically connect an acoustic module of an open-ear headphone to a battery housing of the open-ear headphone. The flexible arm defines an original resting length and position between the acoustic module and the battery housing. The flexible arm includes a flexible printed circuit that extends through the entire original resting length of the flexible arm and comprises a conductor that is configured to carry electrical energy between the acoustic module and the battery housing, and a flexible material that encases at least some of the flexible printed circuit. The length of the flexible printed circuit within the flexible arm is greater than the original resting length of the flexible arm. The flexible printed circuit can thus better accommodate tension or compression on the flexible arm as the flexible arm is bent from its original resting position.Type: GrantFiled: September 1, 2023Date of Patent: February 11, 2025Assignee: Bose CorporationInventors: Thomas Chambers, Caitlin Hanson
-
Patent number: 11856356Abstract: A flexible arm that is configured to be located between and physically and electrically connect an acoustic module of an open-ear headphone to a battery housing of the open-ear headphone. The flexible arm defines an original resting length and position between the acoustic module and the battery housing. The flexible arm includes a flexible printed circuit that extends through the entire original resting length of the flexible arm and comprises a conductor that is configured to carry electrical energy between the acoustic module and the battery housing, and a flexible material that encases at least some of the flexible printed circuit. The length of the flexible printed circuit within the flexible arm is greater than the original resting length of the flexible arm. The flexible printed circuit can thus better accommodate tension or compression on the flexible arm as the flexible arm is bent from its original resting position.Type: GrantFiled: January 28, 2022Date of Patent: December 26, 2023Assignee: BOSE CORPORATIONInventors: Thomas Chambers, Caitlin Hanson
-
Publication number: 20230412966Abstract: A flexible arm that is configured to be located between and physically and electrically connect an acoustic module of an open-ear headphone to a battery housing of the open-ear headphone. The flexible arm defines an original resting length and position between the acoustic module and the battery housing. The flexible arm includes a flexible printed circuit that extends through the entire original resting length of the flexible arm and comprises a conductor that is configured to carry electrical energy between the acoustic module and the battery housing, and a flexible material that encases at least some of the flexible printed circuit. The length of the flexible printed circuit within the flexible arm is greater than the original resting length of the flexible arm. The flexible printed circuit can thus better accommodate tension or compression on the flexible arm as the flexible arm is bent from its original resting position.Type: ApplicationFiled: September 1, 2023Publication date: December 21, 2023Inventors: Thomas Chambers, Caitlin Hanson
-
Publication number: 20230247343Abstract: A flexible arm that is configured to be located between and physically and electrically connect an acoustic module of an open-ear headphone to a battery housing of the open-ear headphone. The flexible arm defines an original resting length and position between the acoustic module and the battery housing. The flexible arm includes a flexible printed circuit that extends through the entire original resting length of the flexible arm and comprises a conductor that is configured to carry electrical energy between the acoustic module and the battery housing, and a flexible material that encases at least some of the flexible printed circuit. The length of the flexible printed circuit within the flexible arm is greater than the original resting length of the flexible arm. The flexible printed circuit can thus better accommodate tension or compression on the flexible arm as the flexible arm is bent from its original resting position.Type: ApplicationFiled: January 28, 2022Publication date: August 3, 2023Inventors: Thomas Chambers, Caitlin Hanson
-
Patent number: 11576963Abstract: The present invention provides compositions and methods related to equine live-attenuated influenza vaccines.Type: GrantFiled: February 27, 2019Date of Patent: February 14, 2023Assignee: University of RochesterInventors: Luis Martinez-Sobrido, Thomas Chambers
-
Patent number: 11500227Abstract: A modular audio system which includes an acoustic module configured to be removably engaged with a head-worn peripheral device. In some examples, the head-worn peripheral device is a pair of eyeglass frames and the acoustic module is configured to removably secure to a socket arranged on the inside face of the temples of the eyeglasses. The acoustic module can slidingly, pivotably, and/or magnetically engage with the socket such that, when secured, the acoustic module is configured to generate acoustic energy in the form of audible sound proximate a user's ear while the user is wearing the head-worn peripheral device. In other examples, the temples of the head-worn peripheral device are configured to slidingly engage with a sleeve, where the sleeve includes a pocket configured to slidingly engage with the acoustic module.Type: GrantFiled: April 30, 2020Date of Patent: November 15, 2022Assignee: Bose CorporationInventors: An Tran, Craig Curtis, Sarah Wolfe, Caitlin Hanson, Jeremy Heaston, Kyle DeCubellis, Zachary Provost, Thomas Chambers, Matthew James Storey, Bennett Alexander Nadeau
-
Publication number: 20220133877Abstract: The present invention provides compositions and methods related to equine live-attenuated influenza vaccines. In one aspect, the invention relates to a composition comprising a multivalent equine live-attenuated influenza vaccine comprising a first live-attenuated influenza virus expressing one or more antigens of a clade 1 H3N8 equine influenza virus; and a second live-attenuated influenza virus expressing one or more antigens of a clade 2 H3N8 equine influenza virus, wherein the second live-attenuated influenza virus expresses HA, NA, or a combination thereof of A/equine/Lancashire/1/2016 H3N8.Type: ApplicationFiled: February 27, 2020Publication date: May 5, 2022Inventors: Luis Martinez-Sobrido, Thomas Chambers, Kendall Wayne King
-
Publication number: 20210341762Abstract: A modular audio system which includes an acoustic module configured to be removably engaged with a head-worn peripheral device. In some examples, the head-worn peripheral device is a pair of eyeglass frames and the acoustic module is configured to removably secure to a socket arranged on the inside face of the temples of the eyeglasses. The acoustic module can slidingly, pivotably, and/or magnetically engage with the socket such that, when secured, the acoustic module is configured to generate acoustic energy in the form of audible sound proximate a user's ear while the user is wearing the head-worn peripheral device. In other examples, the temples of the head-worn peripheral device are configured to slidingly engage with a sleeve, where the sleeve includes a pocket configured to slidingly engage with the acoustic module.Type: ApplicationFiled: April 30, 2020Publication date: November 4, 2021Applicant: Bose CorporationInventors: An Tran, Craig Curtis, Sarah Wolfe, Caitlin Hanson, Jeremy Heaston, Kyle DeCubellis, Zachary Provost, Thomas Chambers, Matthew James Storey, Bennett Alexander Nadeau
-
Publication number: 20210109595Abstract: According to an aspect of the disclosure, a user input device is provided comprising a substrate configured to couple to a user, at least one sensing unit, the at least one sensing unit being coupled to the substrate and being configured to provide an output signal indicative of an amount of deformation of the substrate, and a controller coupled to the at least one sensing unit, the controller being configured to receive, from the at least one sensing unit, the output signal, and determine, based on the output signal, at least one gesture performed by the user.Type: ApplicationFiled: October 9, 2019Publication date: April 15, 2021Inventors: Thomas Claude Bernard Landemaine, Mark B. Andersson, Thomas Chambers, Prateek Nath
-
Publication number: 20200405843Abstract: The present invention provides compositions and methods related to equine live-attenuated influenza vaccines.Type: ApplicationFiled: February 27, 2019Publication date: December 31, 2020Inventors: Luis MARTINEZ-SOBRIDO, Thomas CHAMBERS
-
Patent number: 8137676Abstract: The present invention relates, in general, to attenuated equine influenza viruses having an impaired ability to antagonize the cellular interferon (IFN) response, and the use of such attenuated viruses in vaccine and pharmaceutical formulations. In particular, the invention relates to attenuated equine influenza viruses having modifications to an equine NS1 gene that diminish or eliminate the ability of the NS1 gene product to antagonize the cellular IFN response. These viruses replicate in vivo, but demonstrate decreased replication, virulence and increased attenuation, and therefore are well suited for use in live virus vaccines, and pharmaceutical formulations.Type: GrantFiled: June 1, 2005Date of Patent: March 20, 2012Assignees: Mount Sinai School of Medicine, University of KentuckyInventors: Peter Palese, Adolfo Garcia-Sastre, Thomas Chambers
-
Publication number: 20080254060Abstract: The present invention relates, in general, to attenuated equine influenza viruses having an impaired ability to antagonize the cellular interferon (IFN) response, and the use of such attenuated viruses in vaccine and pharmaceutical formulations. In particular, the invention relates to attenuated equine influenza viruses having modifications to an equine NS1 gene that diminish or eliminate the ability of the NS1 gene product to antagonize the cellular IFN response. These viruses replicate in vivo, but demonstrate decreased replication, virulence and increased attenuation, and therefore are well suited for use in live virus vaccines, and pharmaceutical formulations.Type: ApplicationFiled: June 1, 2005Publication date: October 16, 2008Inventors: Peter Palese, Adolfo Garcia-Sastre, Thomas Chambers